Physician

Monica Vasudev, MD

According to 2025 Medicare claims, Monica Vasudev, MD (NPI: 1598711665) practices allergy/immunology in the Sheboygan, WI market, with the plurality of this provider's patient population coming from Sheboygan, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 53081-3129. Vasudev is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Vasudev's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 194 traditional Medicare patients, billed 42,688 HCPCS/CPT codes, and received $721,605 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,369 prescription claims across 373 beneficiaries totaling $2,102,827 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 278 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $76,998 to $721,605. Similarly, Part D prescription costs have risen steadily, from $126,231 to $2,102,827. In contrast, DME billing represents a smaller volume and rose steadily, from $221 to $2,453.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	102	3,305	$76,998
2016	119	4,545	$145,560
2017	113	19,460	$313,775
2018	126	21,091	$453,926
2019	142	27,262	$613,809
2020	144	31,110	$624,592
2021	152	29,634	$603,456
2022	166	27,125	$550,540
2023	185	42,005	$694,098
2024	194	42,688	$721,605

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	106	768	$126,231
2016	128	971	$164,638
2017	151	1,269	$249,849
2018	190	1,687	$415,094
2019	213	1,918	$1,018,079
2020	223	2,200	$1,433,283
2021	262	2,468	$1,536,257
2022	300	2,682	$1,198,873
2023	332	3,106	$1,534,175
2024	373	3,369	$2,102,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	18	$95
2017	N/R	61	$639
2018	63	210	$1,768
2019	56	190	$8,809
2020	35	193	$20,028
2021	38	176	$19,049
2022	32	152	$17,227
2023	89	285	$21,640
2024	58	278	$20,608

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	99	121	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	61	$79
94060	Test to measure expiratory airflow and volume changes before and after medication administration	44	52	$27
94010	Test to measure expiratory airflow and volume	86	101	$18
95012	Test to measure the level of nitric oxide gas	112	151	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	431	18,660	$392,829
Dupixent Pen	Dupilumab	90	2,450	$351,282
Nucala	Mepolizumab	45	1,260	$166,959
Tezspire	Tezepelumab-Ekko	38	1,064	$157,557
Dupixent Syringe	Dupilumab	26	728	$97,554

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	20	$15,128
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	17	62	$1,578
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,564
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	23	$1,152
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	21	31	$603

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Monica Vasudev, MD?

Tedicare shows public-source Medicare data for Monica Vasudev, MD (NPI 1598711665), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Monica Vasudev, MD have ACO affiliation data?

Monica Vasudev, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Monica Vasudev, MD?

Monica Vasudev, MD is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does Monica Vasudev, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.